TIDMBSC

RNS Number : 0229R

British Smaller Companies VCT2 Plc

13 November 2012

British Smaller Companies VCT2 plc ("the Company")

Interim Management Statement

For the quarter ended 30 September 2012

British Smaller Companies VCT2 plc presents its interim management statement for the period from 1 July to the date of this announcement, including the results for the quarter to 30 September 2012. This constitutes the Company's second interim management statement for the financial year ending 31 December 2012, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.

The total return at 30 September 2012, calculated by reference to the net asset value per Ordinary share and the cumulative dividends paid per Ordinary share, is 100.0 pence per Ordinary share. In the quarter there has been no movement in the total return to Shareholders.

The unaudited net asset value per Ordinary share as at 30 September 2012 was 68.0p (30 June 2012: 68.0p). Not included within this value is the interim dividend of 2.0 pence per Ordinary share and a Special Dividend of 0.5 per Ordinary share which were paid on 26 October 2012.

The number of Ordinary shares in issue at 30 September 2012 was 38,243,718 (30 June 2012: 38,243,718). In addition, at 30 September 2012, the Company held 1,178,356 Ordinary shares in Treasury (30 June 2012: 1,178,356).

Net assets at 30 September 2012 comprised the following:

 
                                       % of net 
                              GBP000     assets 
 
 Unquoted investments at 
  fair value                   9,421       36.2 
 Quoted investments at 
  bid price                    2,124        8.2 
 Gilt investments                919        3.5 
                             -------  --------- 
 Total investments            12,464       47.9 
                             -------  --------- 
 
 Cash and cash equivalents    12,955       49.8 
 Other net current assets        583        2.3 
                             -------  --------- 
 Net assets                   26,002      100.0 
                             =======  ========= 
 

The ten largest investments by valuation at 30 September 2012 were as follows:

 
                                          % of net 
                                 GBP000     assets 
 
 Seven Technologies Limited       1,262        4.8 
 Displayplan Holdings Limited     1,244        4.8 
 Deep-Secure Ltd                  1,055        4.1 
 Immunobiology Limited              987        3.8 
 Digital Healthcare Limited         921        3.6 
 Bluebell Telecom Group 
  Limited                           545        2.1 
 Power Oasis Limited                500        2.0 
 Iomart Group plc                   416        1.6 
 Bagel Nash Limited                 400        1.5 
 Harvey Jones Limited               400        1.5 
 Top ten investments              7,730       29.8 
 
 Other investments                3,815       14.6 
 Gilt investments                   919        3.5 
                                -------  --------- 
 Total investments               12,464       47.9 
                                =======  ========= 
 

During the three months ended 30 September 2012 the Company made a total of 4 investments, two into new portfolio companies and two follow-on investments into existing portfolio companies.

In August the Company invested GBP0.78 million into Insider Technologies Limited, an established provider of monitoring and scheduling software to the financial services and national security sectors, as well as GBP0.125 million into Hargreaves Services plc, Britain's largest bulk haulage company.

In addition, during the period, the Company made two additional follow-on investments into existing portfolio companies. In July the Company invested GBP0.16 million into Vianet Group plc (formerly Brulines Group plc.) a leading provider of monitoring dispense protection systems for draught alcoholic drinks in the UK licensed on-trade. Whilst in August the Company invested GBP0.9 million into Immunobiology Limited, a company involved in the development of high efficacy vaccines for infectious diseases including influenza, tuberculosis, meningitis and hepatitis.

In the 3 months to September 2012 cash proceeds of GBP3.74 million have been received relating to the sale of the Company's holdings in Primal Pictures Limited and Sirigen Group Limited as well as from its part disposal of shares held in May Gurney Integrated Services plc, in total representing a profit of GBP1.82 million on original cost.

Following the end of the period the Company has made part disposals of two AIM listed investments, Brady Plc and Iomart Plc. This raised cash proceeds of GBP190,000 compared to a carrying value at 30 September 2012 of 178,000 giving rise to a return on cost of 2.02 times.

Performance

Valuations have remained stable this quarter. The total return, calculated by reference to the net asset value plus cumulative dividends, has remained constant at 100.0 pence per Ordinary share, with cumulative dividends now representing 32.0 pence per Ordinary share. The Company has also paid an interim and special dividend totalling 2.5 pence per Ordinary share on 26 October 2012.

Outlook

The Board believes that the current economic climate will continue to create investment opportunities in the short to medium term in well run and managed UK businesses that need capital to expand but are facing a shortage of finance. History has shown us that cautious investments made in the low point of the economic cycle have resulted in the highest portfolio returns. Additionally the investment limit applying to venture capital trusts has been increased to GBP5 million per investment in any one year. To take full advantage of this market opportunity the Board is seeking to increase the investment capacity of the Company over the coming months via a joint fund raising offer with British Smaller Companies VCT to raise in aggregate up to GBP15 million in gross proceeds.

13 November 2012

For further information please contact:

   David Hall                YFM Private Equity Limited                            Tel:  0113 294 5039 

Matt Thomas N+1 Singer Tel: 0203 205 7500

This information is provided by RNS

The company news service from the London Stock Exchange

END

IMSZMMMMDFFGZZM

British Smaller Companie... (LSE:BSC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more British Smaller Companie... Charts.
British Smaller Companie... (LSE:BSC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more British Smaller Companie... Charts.